title: [Exacerbation of spasticity induced by serotonin reuptake inhibitors. Letter].
authors.forename: M A
authors.initials: MA
authors.lastname: del Real
authors.forename: A
authors.initials: A
authors.lastname: Hernández
authors.forename: J
authors.initials: J
authors.lastname: Vaamonde
authors.forename: M
authors.initials: M
authors.lastname: Gudín
mesh_terms: D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009128:Muscle Spasticity / Q000209:etiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D020280:Sertraline
chemical_list: D015057:1-Naphthylamine; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline
vernacular_title: Exacerbación de la espasticidad inducida por inhibidores de la recaptación de serotonina.